These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38818914)

  • 21. Remimazolam for Sedation During Upper Gastrointestinal Endoscopy in an Adolescent.
    Garrett A; Flowers J; Ng V; Tobias JD
    J Med Cases; 2022 Oct; 13(10):495-498. PubMed ID: 36407860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.
    Lohmer LL; Schippers F; Petersen KU; Stoehr T; Schmith VD
    J Clin Pharmacol; 2020 Apr; 60(4):505-514. PubMed ID: 31989598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the drug-drug interaction potential for trazpiroben (TAK-906), a D
    Nishihara M; Ramsden D; Balani SK
    Xenobiotica; 2021 Jun; 51(6):668-679. PubMed ID: 33879032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment.
    Lee J; Beers JL; Geffert RM; Jackson KD
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remimazolam
    Chang Y; Huang YT; Chi KY; Huang YT
    PeerJ; 2023; 11():e15495. PubMed ID: 37334113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects.
    Zhou J; Leonowens C; Ivaturi VD; Lohmer LL; Curd L; Ossig J; Schippers F; Petersen KU; Stoehr T; Schmith V
    J Clin Anesth; 2020 Nov; 66():109899. PubMed ID: 32585566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes.
    Tang Y; Yang X; Yu Y; Shu H; Xu J; Li R; Zou X; Yuan S; Shang Y
    Minerva Anestesiol; 2022 Nov; 88(11):939-949. PubMed ID: 35785930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of potential drug interactions mediated by cytochrome P450 and transporters for luseogliflozin, an SGLT2 inhibitor.
    Chino Y; Hasegawa M; Fukasawa Y; Mano Y; Bando K; Miyata A; Nakai Y; Endo H; Yamaguchi JI
    Xenobiotica; 2017 Apr; 47(4):314-323. PubMed ID: 27324291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remimazolam: An Updated Review of a New Sedative and Anaesthetic.
    Hu Q; Liu X; Wen C; Li D; Lei X
    Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target-controlled Infusion of Remimazolam in Healthy Volunteers Shows Some Acute Tolerance.
    Vellinga R; Koomen JV; Eleveld DJ; Stöhr T; Pesic M; Struys MMRF; Colin PJ
    Anesthesiology; 2024 Feb; 140(2):207-219. PubMed ID: 37889844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures.
    Morimoto Y
    Ther Clin Risk Manag; 2022; 18():95-100. PubMed ID: 35140469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies.
    Pedersen MH; Danø A; Englev E; Kattenhøj L; Munk E
    Curr Med Res Opin; 2023 May; 39(5):691-699. PubMed ID: 36999319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive-Unlabeled Learning for inferring drug interactions based on heterogeneous attributes.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2017 Mar; 18(1):140. PubMed ID: 28249566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology.
    Kim KM
    Anesth Pain Med (Seoul); 2022 Jan; 17(1):1-11. PubMed ID: 35139608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization.
    Doohan PT; Oldfield LD; Arnold JC; Anderson LL
    AAPS J; 2021 Jun; 23(4):91. PubMed ID: 34181150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic Influences of Remimazolam Versus Propofol During the Induction Period of General Anesthesia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Peng X; Liu C; Zhu Y; Peng L; Zhang X; Wei W; Zhu T
    Pain Physician; 2023 Nov; 26(7):E761-E773. PubMed ID: 37976477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trials.
    Dao VA; Schippers F; Stöhr T
    Endosc Int Open; 2022 Apr; 10(4):E378-E385. PubMed ID: 35433203
    [No Abstract]   [Full Text] [Related]  

  • 38. Enzyme kinetics for clinically relevant CYP inhibition.
    Zhang ZY; Wong YN
    Curr Drug Metab; 2005 Jun; 6(3):241-57. PubMed ID: 15975042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remimazolam: a short-acting benzodiazepine for procedural sedation.
    Paton DM
    Drugs Today (Barc); 2021 May; 57(5):337-346. PubMed ID: 34061128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impact on Drug-Drug Interaction Produced by Standardized CYP2C8 Inhibitors, Clopidogrel and Gemfibrozil.
    Iga K; Kiriyama A
    Clin Pharmacokinet; 2024 Jan; 63(1):43-56. PubMed ID: 37921907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.